Two SMO inhibitors GDC-0449 (GDC) and BMS-833923 (BMS) for downregulation of SHH signaling was applied to explore whether activation of SHH pathways is involved in growth and clonal expansion of lung cancer cells. This evidence concerns the gene SHH and lung cancer.